dc.creator | Siokas V., Kardaras D., Aloizou A.-M., Asproudis I., Boboridis K.G., Papageorgiou E., Spandidos D.A., Tsatsakis A., Tsironi E.E., Dardiotis E. | en |
dc.date.accessioned | 2023-01-31T09:56:55Z | |
dc.date.available | 2023-01-31T09:56:55Z | |
dc.date.issued | 2019 | |
dc.identifier | 10.1007/s12031-018-1255-3 | |
dc.identifier.issn | 08958696 | |
dc.identifier.uri | http://hdl.handle.net/11615/79037 | |
dc.description.abstract | Blepharospasm (BSP) is a sub-phenotype of focal dystonia. A few genetic risk factors are considered to be implicated in the risk of developing BSP. There is recent evidence, based on results from GWAS and meta-analyses, to suggest that arylsulfatase G (ARSG), and more specifically rs11655081, is implicated in focal dystonia. The aim of the present study was to evaluate the effect of rs11655081 ARSG on BSP. A Greek cohort, which consisted of 206 BSP patients and an equal number of healthy controls, was genotyped for rs11655081. Only a marginal trend for the association between rs11655081 and the risk of BSP was found in the over-dominant model of inheritance [odds ratio, OR (95% confidence interval, CI): 0.64 (0.38–1.07), p = 0.088]. It is rather unlikely that rs11655081 across ARSG is a major genetic risk contributor for BSP. © 2019, Springer Science+Business Media, LLC, part of Springer Nature. | en |
dc.language.iso | en | en |
dc.source | Journal of Molecular Neuroscience | en |
dc.source.uri | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85060218557&doi=10.1007%2fs12031-018-1255-3&partnerID=40&md5=6a2310e35eff488d9ed2e6850a6e6279 | |
dc.subject | arylsulfatase | en |
dc.subject | arylsulfatase g | en |
dc.subject | unclassified drug | en |
dc.subject | arylsulfatase | en |
dc.subject | arylsulfatase G, human | en |
dc.subject | adult | en |
dc.subject | aged | en |
dc.subject | Article | en |
dc.subject | blepharospasm | en |
dc.subject | blood sampling | en |
dc.subject | cohort analysis | en |
dc.subject | controlled study | en |
dc.subject | female | en |
dc.subject | gene frequency | en |
dc.subject | genetic association | en |
dc.subject | genetic risk | en |
dc.subject | genetic variability | en |
dc.subject | genotype | en |
dc.subject | Greece | en |
dc.subject | human | en |
dc.subject | inheritance | en |
dc.subject | major clinical study | en |
dc.subject | male | en |
dc.subject | middle aged | en |
dc.subject | risk assessment | en |
dc.subject | single nucleotide polymorphism | en |
dc.subject | blepharospasm | en |
dc.subject | genetics | en |
dc.subject | Arylsulfatases | en |
dc.subject | Blepharospasm | en |
dc.subject | Humans | en |
dc.subject | Polymorphism, Single Nucleotide | en |
dc.subject | Springer New York LLC | en |
dc.title | Lack of Association of the rs11655081 ARSG Gene with Blepharospasm | en |
dc.type | journalArticle | en |